Dynamic pathway modeling of sphingolipid metabolism
暂无分享,去创建一个
[1] Pedro de Atauri,et al. Metabolic control analysis in drug discovery and disease , 2002, Nature Biotechnology.
[2] J. Gibbs. Mechanism-based target identification and drug discovery in cancer research. , 2000, Science.
[3] John H. Kalivas,et al. Adaption of simulated annealing to chemical optimization problems , 1995 .
[4] James E. Bailey,et al. Lessons from metabolic engineering for functional genomics and drug discovery , 1999, Nature Biotechnology.
[5] C. Sander,et al. Genomic medicine and the future of health care. , 2000, Science.
[6] James F. Rusling,et al. Nonlinear computer modeling of chemical and biochemical data , 1996 .
[7] D. Noble. Modeling the Heart--from Genes to Cells to the Whole Organ , 2002, Science.
[8] H. Kitano,et al. Computational systems biology , 2002, Nature.
[9] Douglas M. Bates,et al. Nonlinear Regression Analysis and Its Applications , 1988 .
[10] Alfred H. Merrill,et al. De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway* , 2002, The Journal of Biological Chemistry.
[11] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.
[12] R. H. J. M. Otten,et al. The Annealing Algorithm , 1989 .